5434 — Topco Scientific Co Balance Sheet
0.000.00%
- TWD46.90bn
- TWD46.05bn
- TWD57.00bn
- 83
- 56
- 85
- 89
Annual balance sheet for Topco Scientific Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,761 | 5,141 | 5,592 | 6,917 | 5,483 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,213 | 8,011 | 8,894 | 8,432 | 10,158 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 14,434 | 16,897 | 20,592 | 20,512 | 21,592 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,731 | 3,970 | 4,176 | 4,347 | 9,860 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 21,452 | 25,174 | 29,880 | 31,636 | 37,275 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,442 | 11,510 | 14,149 | 12,727 | 14,954 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 10,878 | 13,578 | 16,921 | 16,526 | 19,504 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 10,574 | 11,597 | 12,960 | 15,109 | 17,771 |
Total Liabilities & Shareholders' Equity | 21,452 | 25,174 | 29,880 | 31,636 | 37,275 |
Total Common Shares Outstanding |